Catabasis Pharmaceuticals (CATB) Stock Climbs in After-Hours Trading After IPO

NEW YORK (TheStreet) -- Catabasis Pharmaceuticals (CATB) shares are climbing 0.92% to $13.12 in after-hours trading on Thursday after the company gained 8.33% to $13 in intraday trading following its initial public offering.

The Cambridge, MA-based clinical stage biopharmaceutical company priced its upsized sale of 5 million shares at $12 per share.

Catabasis, a company that develops technology for improving drug efficacy, priced its IPO below analysts' $13 to $15 expectations.

CATB Price Chart CATB Price data by YCharts

More from Markets

To Win at Trade the U.S. Must Act and Behave Like China

To Win at Trade the U.S. Must Act and Behave Like China

Dow Rises Sharply as U.S.-China Trade Tensions Thaw

Dow Rises Sharply as U.S.-China Trade Tensions Thaw

Video: Jim Cramer on Tariffs, the Market Rally, Caterpillar and Micron

Video: Jim Cramer on Tariffs, the Market Rally, Caterpillar and Micron

Apple Shares Gain as U.S. and China Call Off Trade War, For Now

Apple Shares Gain as U.S. and China Call Off Trade War, For Now

GE Confirms $11.1 Billion Transportation Merger With Wabtec

GE Confirms $11.1 Billion Transportation Merger With Wabtec